The Finnish wearable technology maker behind the widely used Oura Ring has engaged in a significant lobbying effort in Washington, D.C., as the device cemented its presence among policymakers and sought to help shape how wearable health technology is regulated in the United States. Companies like Oura have poured substantial resources into advocacy at a time when health policy and wearable technology intersect more visibly than ever.
According to reporting from Politico, Oura Health has dramatically expanded its influence operation on Capitol Hill and at federal agencies, spending more than $1 million on lobbying in 2025—up sharply from roughly $40,000 the previous year. The company’s efforts have included hiring high-profile firms with ties to the former Trump administration, positioning itself as a key player amid evolving health legislation and regulatory policy.
Central to Oura’s advocacy is its push to reconsider how wearable devices are classified under U.S. law. The company has called on Congress and federal regulators to create a new category for what it describes as “low-risk” wearable health tools—allowing such devices to offer early warning signals about health changes without undergoing the lengthy clearance process required for medical devices by the Food and Drug Administration (FDA).
The debate over regulation comes as the Oura Ring has gained ground inside and outside government circles. Lawmakers and staffers are increasingly spotted wearing Oura Rings, which use sensors to collect biometric data like heart rate, sleep patterns, and temperature. The resurgence of focus on wearable tech in policy discussions coincides with Secretary of Health and Human Services Robert F. Kennedy Jr.’s “Make America Healthy Again” initiative—a health agenda that has promoted wider adoption of wearable health tools among Americans.
Oura’s push has sparked divided reactions across the tech, medical, and policy communities. Advocates argue that current classifications do not reflect the capabilities of modern wearables and may stifle innovation. Critics counter that loosening rules could blur critical lines between wellness products and medical devices, potentially leading users to make decisions based on unverified health indicators. Regardless of stance, most observers agree the debate underscores the complexities of regulating rapidly evolving technology.
One area of particular debate is the intersection between wearable health tracking, data ownership, and privacy. The Oura Ring collects sensitive biometric data on users, raising questions about who ultimately controls that information and how it might be used. Lawmakers have expressed interest in policies that would increase protections for wearable-generated data, aligning it more closely with traditional medical records. However, such proposals could impose significant compliance costs on device makers and complicate innovation.
Joanne Frederick, founder of Government Market Strategies, a leading force in government healthcare consulting, weighed in on the policy implications.
“The Oura Ring is a powerful feedback tool that gives individuals insight into their own ‘operating system’ each day. As a consistent subscriber since 2020, I’ve seen how access to real-time health data can increase awareness and personal accountability. From a policy standpoint, empowering people to better understand their own health is a positive development. Where things become more complicated is when government sponsorship of a device potentially intersects with access to personal health data. Any public-sector partnership involving wearable technology must draw a bright line around individual data ownership and privacy. The goal should be to create cultures and structures that strengthen personal agency — not systems that centralize sensitive health information.”
This sentiment shows what the future may hold in regards to health tech policy: how to harness the benefits of real-time health insights without entrusting sensitive data to entities that might misuse it. The debate over data ownership gains urgency as government agencies consider partnerships with private firms and explore ways to integrate wearable data into public health initiatives.
Oura’s lobbying has also included opposition to proposals that would require wearable health data to be treated like protected health information under the Health Insurance Portability and Accountability Act (HIPAA). While privacy advocates assert that HIPAA-style protections are essential in safeguarding consumer data, industry representatives argue that such rules could hinder product development and adoption.
As Oura and other wearable makers continue to push for policy changes, lawmakers and regulators appear poised to weigh the competing priorities of innovation, consumer protection, and data privacy. What remains clear is that health wearables like the Oura Ring are no longer niche gadgets but substantive pieces in the broader conversation about the future of health technology in the United States.